Clinical Trials Browser

Phase EARLY_PHASE1 × Nadolol × Other hematologic neoplasm × Clear all

NCT06643221 2024-10-16

Allo-X

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Motor Activity